AU2002325201B2

AU2002325201B2 - A cartridge for liquid insulin

Info

Publication number: AU2002325201B2
Application number: AU2002325201A
Authority: AU
Inventors: Steffen Hansen; Lars Peter Klitmose; Lars Thougaard Kristensen
Original assignee: Novo Nordisk AS
Current assignee: Novo Nordisk AS
Priority date: 2001-08-31
Filing date: 2002-08-23
Publication date: 2007-11-01
Anticipated expiration: 2022-08-23
Also published as: ZA200400344B; IL159901A0; KR20040029015A; WO2003017914A1; RU2299723C2; PL367865A1; ATE300933T1; DK1424984T3; CN1547459A; DE60205390T2; ES2247366T3; EP1424984B1; DE60205390D1; CA2457943A1; JP2005507682A; RU2004109579A; EP1424984A1; CN1264493C

Abstract

A glass cartridge which can be utilized both in an insulin pump system and in an insulin injection system. According to the invention, the glass cartridge contains U200 insulin. In order to obtain a suitable accuracy of the doses delivered by the system, the inside diameter of the cartridge must be in the range 7,45 to 9,32 mm.

Description

-1- C- A Cartridge for Liquid Insulin 0 The technical field of the invention: In one or more embodiments, the invention relates to ampoules or cartridges for insulin O delivery systems. Such cartridges are commonly shaped as a glass tube being at one end t closed by a piston, which may be pressed into the tube to expel the content of the tube at the other end of the tube. This other end is formed as a bottleneck, the outer end of which may be pierced by an injection needle or a catheter through which the content is ,i 10 expelled.

Description of related art: Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of common general knowledge in the field.

Glass cartridges are widely known for various medicament delivery systems. They are especially used for insulin delivery systems, and are usually supplied pre-filled with either 1,5 ml of insulin or 3.0 ml of insulin. A 1,5 ml cartridge usually has an inside diameter around 6,85 mm and a 3,0 ml cartridge usually has an inside diameter around 9,25 mm. These known cartridges are pre-filled with insulin having a concentration of 100 International Units (IU) per ml. A 1,5 ml cartridge therefore contains 150 IU and a ml cartridge contains 300 IU.

The typical diabetes patient will require a certain amount of insulin either injected or infused into their body every day. Some patients need as much as 100 IU per day, in which case the 3,0 ml cartridge is recommended. The patient loads the cartridge into either an injection system or a pump system and injects or infuses the insulin into their body at a prescribed rate, either through an injection needle or through a catheter inserted into their body. Once the cartridge is empty it is disposed of and a new cartridge is loaded into the delivery system.

-2- O Glass is the most preferred material for cartridges containing insulin, since glass is both chemically and biologically inert so that insulin can be stored within the glass cartridge O without reactions occurring between the liquid insulin and the glass material. Glass has the additional advantage that it can be thermally sterilized. Glass cartridges are produced from long glass tubes, which are cut up into smaller tubes, one end of which is melted so that a small opening remains. The opposite open end of the tubes is provided with a Smovable piston, which is usually manufactured from rubber or plastic.

Cartridges made from glass however have the disadvantage that the inside diameter is 10 variable due to the manufacturing process. The inside diameter of glass cartridges, varies by 0,1 mm at an average inside diameter of about 10 mm. However, finer tolerances are available by pre sorting the glass cartridges or by tightened monitoring of the glass process. The following table shows the tolerances typically available today: Inside diameter 7 7,5 8 9,25 10 11 12 Tolerances 0,05 0,05 0,06 0,06 0,08 0,09 0,1 These tolerances are a major problem for the dose accuracy of the injected or infused insulin. The dose accuracy of an insulin delivery system is the subject of the ISO standard 11608-1. This standard prescribes that a dose in the range 0 to 20 IU must have an accuracy of IU, i.e. a nominal dose of 20 IU must contain between 19 to 21 IU.

The ISO standard allows a tolerance of doses smaller than 20 IU to be within 1 IU, while the tolerances of a dose exceeding 20 IU must be within 5 The most difficult part of the standard to meet is therefore typically the demand for accuracy on+/- 1 IU for a dose of A large diameter combined with a large tolerance provides large variations in the cross section area of the glass cartridge, which will result in large tolerances in the volume delivered by the insulin delivery system. This is however not a major problem when the insulin has a concentration on only 100 IU per ml.

1" -2a- SSummary of the Invention: c, O According to a first aspect, the present invention provides a glass cartridge for a precision insulin delivery system, said cartridge comprising a distal end and a proximal end connected by a cylindrical wall forming a vessel containing liquid insulin, the distal end being provided with a flange closed by a flexible membrane sealingly secured (,i t against the flange, and the proximal end being closed by a piston which can be moved (,i Cc into said cartridge which accommodates the liquid insulin in the variable space between (,i the flexible membrane and a front wall of the piston, wherein the liquid insulin is an (N 10 U200 insulin, and wherein the cylindrical wall has an inside diameter in the range 7,45 mm to 9,31 mm, such that said cartridge can be utilized both in an insulin pump system and in an insulin injection system According to a second aspect, the present invention provides a method for precisely delivering insulin, using a precision insulin delivery system including a glass cartridge, according to the first aspect.

Unless the context clearly requires otherwise, throughout the description and the claims, the words "comprise", "comprising", and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to".

It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative.

Description of the invention: It is a constant aim for manufacturers of insulin delivery systems to minimize their systems. A delivery system however always has to include a cartridge. Manufacturers therefore have a great demand for smaller and more compact cartridges. Never the less no one wants to compromise the number of International Units contained in the cartridge. One way of solving this Gordian knot is by increasing the concentration of the 2b

O

O insulin contained in the cartridge. By increasing the concentration up to 200 IU per ml, a ml cartridge is capable of containing 300 IU.

O

With the before mentioned large variations in the cross section area of the glass cartridges it will apparently be increasingly difficult to meet the ISO 11608-1 standard when using a liquid U200 insulin.

WO 03/017914 PCT/DK02/00553 3 In the table in figure 1, the displacement accuracy is calculated for different dimensions of glass cartridges. The two first columns show the different dimensions and tolerances of the inner diameter of various cartridges. The nominal and maximal cross section areas of the cartridges are calculated in column 3 and 4. Column 5 recites the insulin concentration.

The distance the front wall of the piston most be moved forward inside the cartridge in order to expel I IU of insulin is calculated in column 6. This movement is calculated on basis of the nominal diameter using the following formula:

V

H t. R 2 V: Volume R: Radius H: Displacement One IU of liquid U200 insulin has the volume of 0,005 ml, the front wall of the piston in e.g. a cartridge having a nominal inside diameter of 9,25 mm most therefore be displaced by 0,074 mm in order to expel one IU.

Column 7 indicates how much the tolerances in the cross section area influence the dose accuracy. It can be seen that for a cartridge with a nominal diameter of 9,25 mm, 0,260 IU of the tolerance on 1 IU given in the ISO standard are consumed by the tolerance of the cross section area of the cartridge. The tolerance is calculated by extracting the minimum cross section area from the maximum cross section area shown in column 4, and multiplying this difference with the one unit displacement shown in column 6 and with the insulin concentration. The remaining 0,740 IU shown in column 8 are then available for the imprecision of the insulin delivery system, including the slack of interface to the cartridge.

The remaining part of the tolerance listed in column 8, is in column 9 expressed in millimeters by multiplying the displacement needed for expelling 1 IU with the remaining tolerance available for the imprecision of the insulin delivery system.

WO 03/017914 PCT/DK02/00553 4 Once again reciting the numerals for a cartridge having a nominal inside diameter of 9,25 mm, the front wall of the piston most be moved a distance equal to 20 times 0,074 mm i.e.

1,488 mm 0,055 mm (from 1,433 to 1,543 mm) in order to deliver a dose of 20 IU within a tolerance of 1 IU.

The volume expelled within these tolerances can be calculated using the following formula: V(IU) CS D IC V(IU) :Volume expressed in IU CS Cross section area of the cartridge R 2 D Displacement of piston IC Insulin concentration The following table show the expelled volume measured in International Units for a cartridge having a nominal diameter of 9,25 mm and tolerances of 0,06 mm, i.e. an inside diameter between 9,19 mm and 9,31 mm, equaling a cross section area of the volumen of the cartridge between 66,33 mm 2 and 68,08 mm 2 when the cartridge is used in an insulin delivery system which can move the piston forward with a tolerance of 0,055 mm. The forward movement hence being in the range 1,433 mm to 1,543 mm.

1,433 mm 1,488 mm 1,543 mm 66,33 mm 2 19,01 IU 19,74 IU 20,47 IU 67,20 mm 2 19,26 IU 19,99 IU 20,74 IU 68,08 mm 2 19,51 IU 20,26 IU 21,00 IU SThe mechanical insulin delivery systems available today all have quite a large imprecision due to the mechanical system. The leading injection devices have a O displacement accuracy around meaning that the front wall of the piston can only be moved forward within tolerances of approximately +/-0,083 mm. When using U200 insulin the maximum allowable inner diameter of the cartridge must, according to O the table shown in figurel be smaller than a nominal 7,5 mm cartridge in order to meet n the demands set up in the ISO 11608-1 standard. Cartridges having an inside diameter Cc larger than 7,5 mm need a displacement accuracy smaller than+/-0,083 mm in order to meet the ISO standard. They are therefore not suitable for use in ordinary insulin pen S 10 systems.

Insulin pumps for pump treatment of diabetes usually have a more precise mechanism than mechanical injection devices due to the presence of a motor mechanism, which is also the case for motor driven injection devices. It is however not necessary with a precise mechanism in insulin pumps due to the presence of a continuous insulin delivery profile.

In recent years mechanical precision injection devices have been developed which have a higher degree of accuracy than the known injection devices. In fact these new injection devices are able to move the piston forward within tolerances of approximately +/-0,055 mm.

As described herein, cartridges containing liquid U200 insulin and having a diameter from the lower tolerance limit of a nominal 7,5 mm cartridge i.e. 7,45 mm to the upper tolerance limit of a nominal 9,25 mm cartridge i.e. 9,31 can be used both in pumps and in precision injection devices having tolerances within 055 mm to +/-0,083 mm, without dispensing from the requirements of ISO 11608-1.

A glass cartridge having an inside diameter between 7,45 and 9,31 mm will, when filled with a liquid U200 insulin, be able to fulfil the ISO 11608-1 standard when the cartridge is being used in a precision insulin delivery system having a displacement accuracy of the mechanism advancing the piston within the range from 0,055 mm to 0,083 mm.

Glass cartridges with an inside diameter in the claimed range can therefore be used both in insulin pump systems and in insulin injection systems.

0 WO 03/017914 PCT/DK02/00553 6 When operating in the lower range of the inside diameters specified in claim 1 it is ensured that, such as disclosed in claim 2, the cartridge can be made very slim and with very narrow tolerances, leaving maximum tolerances for the imprecision of the insulin delivery system.

A glass cartridge having a nominal inside diameter of 7,5 mm needs a length of the stroke zone of approximately 34 mm in order to contain a volume of approximately 1,5 ml. When containing 1,5 ml of a liquid U200 insulin, the total amount of International Unit is 300 IU, which for most patient will be sufficient for three days of treatment. When using the cartridge in a pump system, the pump is usually connected to the body of the user through a catheter.

Due to inflammation of the skin at the site where the catheter is inserted, it is normally recommended to change the catheter and the site approximately every third day. A cartridge containing insulin for minimum three days are therefore to be preferred.

Due to the size of the connecting zone and the piston zone, the overall length of such a cartridge will be approximately 52 mm.

When operating in the upper range of the inside diameters specified in claim 1 it is ensured that, such as disclosed in claim 5, the cartridge can be made very short and still leave sufficient tolerances for the imprecision of the insulin delivery system. A glass cartridge having a nominal inside diameter of 9,25 mm needs a length of the stroke zone of approximately 23 mm in order to contain a volume of approximately 1,5 ml, resulting in an overall length of approximately 44 mm.

Brief Description of the Drawings: The invention will be explained more fully below in connection with a preferred embodiment and with reference to the drawings in which: Figure 1 Shows a table of the displacement accuracy for different cartridge designs Figure 2 Shows a glass cartridge including needle penetration according to the invention.

WO 03/017914 PCT/DK02/00553 7 The figures are schematic and simplified for clarity, and they just show details, which are essential to the understanding of the invention, while other details are left out. Throughout, the same reference numerals are used for identical or corresponding parts.

Detailed Description of Embodiment: A table of the displacement accuracy for different cartridge designs is shown in figure 1.

Glass cartridges containing a liquid U200 insulin and having a nominal diameter between mm and 9,25 mm leaves room for a displacement accuracy between 0,083 and 0,055 mm, which is needed if the cartridge shall be used both for injection devices and for pump systems and fulfil the ISO 11608-1 standard. It can also be seen from the table in figure 1 that the displacement accuracy of an insulin delivery system using a cartridge having a nominal diameter of 9,25 mm must be 0,084 mm when the cartridge contains a liquid U1 00 insulin.

Referring to figure 2 it may be convenient to define that, the term "distal end" of the cartridge 1 is meant to refer to the end carrying the conduit 7 through which the insulin is expelled, whereas the term "proximal end" is meant to refer to the opposite end carrying the piston 9.

A cartridge 1 comprising a cylindrical wall 2 is disclosed in figure 2. The cylindrical wall 2 is at the distal end 10 of the cartridge terminated in a neck part ending in a circumferential flange 3 against which a piercable and flexible membrane 4 is held sealingly by a metal cap 5. At a central part of the membrane 4 the metal cap 5 has an opening 6 through which the membrane 4 is exposed. A hollow conduit 7, such as an injection needle or a catheter can be stuck through the membrane 4 to communicate with the inner space of the cartridge 1 in which the liquid insulin is stored between the membrane 4 and a front wall 8 of a piston 9 which fits into the cartridge 1.

The piston 9 is usually made from a suitable rubber material, such that it is tightly sealed against the inside of the cylindrical wall 2. The inside diameter of the glass cartridge is indicated with D in figure 1.

The cartridge 1 is divided into three different zones. The first zone is the connecting zone C, which extends from the distal end 10 of the cartridge 1 to the shoulder 12. Due to the reduced diameter of the cylindrical wall 2 of the cartridge 1 on the part of the cylindrical wall 2 WO 03/017914 PCT/DK02/00553 8 lying between the distal end 10 of the cartridge 1 and the shoulder 12, the piston 9 cannot be moved beyond the shoulder 12 and into the neck part area of the cartridge 1. The insulin contained in the neck part of the cartridge 1 can therefore not be pressed out of the cartridge, and will hence be disposed of when the cartridge 1 is discarded.

The second zone is the stroke zone S, which extends from the shoulder 12 to the front wall 8 of the piston 9. Only the insulin contained in the stroke zone can be utilized for injection or infusion.

The third zone is the piston zone P, which extends from the proximal end 11 of the cartridge 1 to the front wall 8 of the piston 9. This piston zone P holds the piston 9 and is therefore not available for the insulin contained in the cartridge 1.

The liquid insulin captured between the front wall 8 of the piston 9 and the flexible membrane 4 and within the inside diameter D of the cylindrical wall 2 will be pressed out through the hollow conduit 7, which at the not shown other end is inserted into the person in need for insulin, when the piston 9 is moved forward inside the cartridge 1.

Some preferred embodiments have been shown in the foregoing, but it should be stressed that the invention is not limited to these, but may be embodied in other ways within the subject matter defined in the following claims.

Claims

2. A glass cartridge for a precision insulin delivery system according to claim 1, wherein the inside diameter of said cartridge is in the range of 7,45 to 7,55 mm.
3. A glass cartridge for a precision insulin delivery system according to claim 2, wherein said cartridge has three zones: a connecting zone, a stroke zone and a piston zone, the stroke zone having a length of approximately 34 mm, such that the stroke zone has a volume of approximately 1,5 ml.
4. A glass cartridge for a precision insulin delivery system according to claim 3, wherein the total length of said cartridge is approximately 52 mm. A glass cartridge for a precision insulin delivery system according to claim 1, wherein the inside diameter of said cartridge is in the range of 9,19 to 9,31 mm.
6. A glass cartridge for a precision insulin delivery system according to claim wherein said cartridge has three zones: a connecting zone, a stroke zone and a piston zone, the stroke zone having a length of approximately 23 mm, such that the stroke zone has a volume of approximately 1,5 ml.
7. A glass cartridge for a precision insulin delivery system according to claim 6, wherein the total length of said cartridge is approximately 44 mm. O
8. A method for precisely delivering insulin, using a precision insulin delivery 0 system including a glass cartridge, according to any one of the preceding claims.
9. A glass cartridge for a precision insulin delivery system, substantially as herein described with reference to any one or more of the examples but excluding comparative Sexamples. (N, A method for precisely delivering insulin, substantially as herein described with E",1 10 reference to any one or more of the examples but excluding comparative examples.